ELUT Elutia | $3.27 +2.8% | 6/18/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 -> $11.00 | Low | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 6/18/2024 |
IMVT Immunovant | $26.19 -2.3% | 6/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Immunovant (NASDAQ:IMVT) on 6/18/2024 |
ROIV Roivant Sciences | $10.84 +1.1% | 6/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Roivant Sciences (NASDAQ:ROIV) on 6/18/2024 |
NTLA Intellia Therapeutics | $24.80 -1.5% | 6/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/18/2024 |
CLDX Celldex Therapeutics | $34.66 -0.7% | 6/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $67.00 -> $67.00 | Low | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 6/18/2024 |
INCY Incyte | $61.44 -2.0% | 6/18/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral | | Low | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 6/18/2024 |
|
JSPR Jasper Therapeutics | $23.19 -4.6% | 6/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Jasper Therapeutics (NASDAQ:JSPR) on 6/18/2024 |
AMRN Amarin | $0.73 -3.9% | 6/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Amarin (NASDAQ:AMRN) on 6/18/2024 |
CATX Perspective Therapeutics | $11.93 +15.4% | 6/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Perspective Therapeutics (NYSE:CATX) on 6/18/2024 |
MRK Merck & Co., Inc. | $127.99 +0.4% | 6/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $155.00 -> $155.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 6/18/2024 |
INVA Innoviva | $16.22 +0.4% | 6/18/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Innoviva (NASDAQ:INVA) on 6/18/2024 |
LLY Eli Lilly and Company | $891.46 +0.7% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $885.00 -> $885.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 6/17/2024 |
NVO Novo Nordisk A/S | $140.80 +0.3% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 -> $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 6/17/2024 |
GPCR Structure Therapeutics | $47.52 -2.2% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 6/17/2024 |
PFE Pfizer | $27.41 +1.6% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 6/17/2024 |
SKYE Skye Bioscience | $9.51 -12.4% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $14.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of Skye Bioscience (NASDAQ:SKYE) on 6/17/2024 |
SKYE Skye Bioscience | $9.51 -12.4% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $14.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of Skye Bioscience (NASDAQ:SKYE) on 6/17/2024 |
RIVN Rivian Automotive | $11.02 +0.5% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $15.00 -> $15.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 6/17/2024 |
ACHR Archer Aviation | $3.07 -3.2% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 6/17/2024 |
JOBY Joby Aviation | $5.00 +1.6% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Joby Aviation (NYSE:JOBY) on 6/17/2024 |
LUNR Intuitive Machines | $3.68 -1.6% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 6/17/2024 |
OUST Ouster | $10.68 -2.1% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $13.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 6/17/2024 |
MU Micron Technology | $153.45 +3.8% | 6/17/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $150.00 -> $180.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 6/17/2024 |
AGIO Agios Pharmaceuticals | $42.56 -0.1% | 6/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 6/17/2024 |
TGB Taseko Mines | $2.58 +3.2% | 6/13/2024 | Upgraded by | Cantor Fitzgerald | Analyst M. Kozak | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Taseko Mines (NYSE:TGB) on 6/13/2024 |
ITCI Intra-Cellular Therapies | $75.48 +9.6% | 6/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 -> $120.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 6/14/2024 |
RIOT Riot Platforms | $10.66 -2.3% | 6/12/2024 | Upgraded by | Cantor Fitzgerald | Analyst B. Knoblauch | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 6/12/2024 |
IREN Iris Energy | $13.95 -3.5% | 6/12/2024 | Upgraded by | Cantor Fitzgerald | Analyst B. Knoblauch | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 6/12/2024 |
CLSK CleanSpark | $19.48 +1.2% | 6/12/2024 | Upgraded by | Cantor Fitzgerald | Analyst B. Knoblauch | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 6/12/2024 |
BTDR Bitdeer Technologies Group | $9.08 -3.2% | 6/12/2024 | Upgraded by | Cantor Fitzgerald | Analyst B. Knoblauch | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 6/12/2024 |
ETNB 89bio | $8.40 -5.2% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 -> $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 6/12/2024 |
MREO Mereo BioPharma Group | $3.98 -6.4% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 6/12/2024 |
RARE Ultragenyx Pharmaceutical | $37.42 -6.0% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $115.00 -> $115.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 6/12/2024 |
CI The Cigna Group | $334.81 +0.3% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $400.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 6/12/2024 |
CNC Centene | $66.39 -2.7% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 -> $90.00 | Low | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 6/12/2024 |
CVS CVS Health | $61.02 -0.1% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Neutral -> Neutral | $58.00 -> $58.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 6/12/2024 |
ELV Elevance Health | $527.49 -1.3% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $600.00 -> $600.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 6/12/2024 |
HUM Humana | $349.55 -1.6% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $360.00 -> $360.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 6/12/2024 |
UNH UnitedHealth Group | $481.05 -1.7% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 -> $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 6/12/2024 |
RBRK Rubrik | $30.65 -1.4% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $50.00 -> $50.00 | Low | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 6/12/2024 |
[Urgent] Protect your money before November (Ad) Those who listened to his warnings could have kept their money safe and even made substantial profits during each crisis.
In fact, the Wall Street Journal reported that his work was more accurate … and more profitable than that of …
Deutsche Bank … Merrill Lynch … JPMorgan Chase … Goldman Sachs … and every other firm reviewed. Click here to watch now. |
AKRO Akero Therapeutics | $22.16 -3.3% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Akero Therapeutics (NASDAQ:AKRO) on 6/12/2024 |
TSLA Tesla | $184.86 -1.4% | 6/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $230.00 -> $230.00 | Low | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 6/12/2024 |
ZURA Zura Bio | $3.38 -9.4% | 6/12/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | | Low | View details for Cantor Fitzgerald rating of Zura Bio (NASDAQ:ZURA) on 6/12/2024 |
DM Desktop Metal | $4.98 +36.1% | 6/11/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $1.25 -> $12.50 | Low | View details for Cantor Fitzgerald rating of Desktop Metal (NYSE:DM) on 6/11/2024 |
LLY Eli Lilly and Company | $891.46 +0.7% | 6/11/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $885.00 -> $885.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 6/11/2024 |
WDC Western Digital | $80.23 +0.5% | 6/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $100.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 6/11/2024 |
CLSK CleanSpark | $19.48 +1.2% | 6/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 -> $27.00 | Low | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 6/11/2024 |
RIOT Riot Platforms | $10.66 -2.3% | 6/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 -> $23.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 6/11/2024 |
BITF Bitfarms | $3.15 +0.3% | 6/11/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $4.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 6/11/2024 |
CIFR Cipher Mining | $5.01 +0.2% | 6/11/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $5.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 6/11/2024 |
WULF TeraWulf | $4.51 +2.7% | 6/11/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $4.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 6/11/2024 |
IREN Iris Energy | $13.95 -3.5% | 6/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | $23.00 | Low | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 6/11/2024 |
BTDR Bitdeer Technologies Group | $9.08 -3.2% | 6/11/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $13.00 | Low | View details for Cantor Fitzgerald rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 6/11/2024 |
PWSC PowerSchool | $22.35 +0.2% | 6/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Neutral | $25.00 -> $22.80 | Low | View details for Cantor Fitzgerald rating of PowerSchool (NYSE:PWSC) on 6/7/2024 |
TMDX TransMedics Group | $145.96 +2.0% | 6/6/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $161.00 | Low | View details for Cantor Fitzgerald rating of TransMedics Group (NASDAQ:TMDX) on 6/6/2024 |
CXM Sprinklr | $8.56 -2.9% | 6/6/2024 | Downgraded by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Neutral | $16.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 6/6/2024 |
CRWD CrowdStrike | $389.51 -0.2% | 6/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 6/5/2024 |
ANNX Annexon | $5.07 -5.4% | 6/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 6/5/2024 |
XMTR Xometry | $12.55 +0.1% | 6/5/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Underweight | $13.00 | Low | View details for Cantor Fitzgerald rating of Xometry (NASDAQ:XMTR) on 6/5/2024 |
PRLB Proto Labs | $30.07 -0.8% | 6/5/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $44.00 | Low | View details for Cantor Fitzgerald rating of Proto Labs (NYSE:PRLB) on 6/5/2024 |
MESO Mesoblast | $7.49 +3.5% | 6/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 6/4/2024 |
GTLB GitLab | $43.01 -1.0% | 6/4/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $70.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 6/4/2024 |
MRK Merck & Co., Inc. | $127.99 +0.4% | 6/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $155.00 -> $155.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 6/4/2024 |
NTLA Intellia Therapeutics | $24.80 -1.5% | 6/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/4/2024 |
GPCR Structure Therapeutics | $47.52 -2.2% | 6/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 6/3/2024 |
XFOR X4 Pharmaceuticals | $0.97 -3.0% | 5/31/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 5/31/2024 |
RARE Ultragenyx Pharmaceutical | $37.42 -6.0% | 5/31/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 -> $115.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/31/2024 |
MRVL Marvell Technology | $73.14 +1.8% | 5/31/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $85.00 -> $85.00 | Low | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 5/31/2024 |
ZS Zscaler | $179.41 -2.7% | 5/31/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 5/31/2024 |
NET Cloudflare | $79.12 +1.9% | 5/31/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $80.00 -> $80.00 | Low | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 5/31/2024 |
RBRK Rubrik | $30.65 -1.4% | 5/31/2024 | Initiated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $50.00 -> $50.00 | Low | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 5/31/2024 |
BHVN Biohaven | $32.77 -0.7% | 5/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 5/30/2024 |
IMVT Immunovant | $26.19 -2.3% | 5/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Immunovant (NASDAQ:IMVT) on 5/30/2024 |
SSYS Stratasys | $8.21 +0.1% | 5/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $23.00 -> $23.00 | Low | View details for Cantor Fitzgerald rating of Stratasys (NASDAQ:SSYS) on 5/30/2024 |
CDXS Codexis | $2.73 -8.4% | 5/30/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $11.00 | Low | View details for Cantor Fitzgerald rating of Codexis (NASDAQ:CDXS) on 5/30/2024 |
ADCT ADC Therapeutics | $2.72 -3.5% | 5/30/2024 | Initiated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of ADC Therapeutics (NYSE:ADCT) on 5/30/2024 |
ALXO ALX Oncology | $6.93 -6.1% | 5/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 5/29/2024 |
NNOX Nano-X Imaging | $7.23 -4.1% | 5/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $18.00 -> $18.00 | Low | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 5/29/2024 |
BBIO BridgeBio Pharma | $27.61 +1.4% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $70.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 5/28/2024 |
LUNR Intuitive Machines | $3.68 -1.6% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 5/28/2024 |
RDW Redwire | $6.10 +3.4% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $6.00 -> $6.00 | Low | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 5/28/2024 |
RKLB Rocket Lab USA | $4.91 +13.1% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $6.00 | Low | View details for Cantor Fitzgerald rating of Rocket Lab USA (NASDAQ:RKLB) on 5/28/2024 |
ORIC ORIC Pharmaceuticals | $7.18 -3.5% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 5/28/2024 |
TSHA Taysha Gene Therapies | $2.97 -26.3% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 5/28/2024 |
IRON Disc Medicine | $43.54 -2.9% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $85.00 -> $85.00 | Low | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 5/28/2024 |
ALKS Alkermes | $24.42 -2.4% | 5/23/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 -> $48.00 | Low | View details for Cantor Fitzgerald rating of Alkermes (NASDAQ:ALKS) on 5/23/2024 |
NVDA NVIDIA | $135.58 +3.5% | 5/23/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $120.00 -> $140.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 5/23/2024 |
SKYE Skye Bioscience | $9.51 -12.4% | 5/23/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $21.00 | Low | View details for Cantor Fitzgerald rating of Skye Bioscience (NASDAQ:SKYE) on 5/23/2024 |
SKYE Skye Bioscience | $9.51 -12.4% | 5/23/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $21.00 | Low | View details for Cantor Fitzgerald rating of Skye Bioscience (NASDAQ:SKYE) on 5/23/2024 |
OUST Ouster | $10.68 -2.1% | 5/22/2024 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $8.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 5/22/2024 |
The asset beating inflation by 4x (Ad) Central Bank Gold Heist In Progress
Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Precious Metals Guide, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too. Click here to get your free copy today. |
ZLDPF Zealand Pharma A/S | $90.80 -3.0% | 5/21/2024 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | Low | View details for Cantor Fitzgerald rating of Zealand Pharma A/S (OTCMKTS:ZLDPF) on 5/21/2024 |
UBSFY Ubisoft Entertainment | $4.54 +1.3% | 5/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst E. James | Neutral -> Overweight | | Low | View details for Cantor Fitzgerald rating of Ubisoft Entertainment (OTCMKTS:UBSFY) on 5/20/2024 |
FULC Fulcrum Therapeutics | $6.49 -7.3% | 5/20/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $23.00 | Low | View details for Cantor Fitzgerald rating of Fulcrum Therapeutics (NASDAQ:FULC) on 5/20/2024 |
ETNB 89bio | $8.40 -5.2% | 5/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 5/17/2024 |
AMAT Applied Materials | $247.83 +2.0% | 5/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $260.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 5/17/2024 |
DESP Despegar.com | $13.91 +4.6% | 5/17/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $17.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 5/17/2024 |
ABBV AbbVie | $171.35 +1.0% | 5/17/2024 | Initiated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | $200.00 | Low | View details for Cantor Fitzgerald rating of AbbVie (NYSE:ABBV) on 5/17/2024 |
PGNY Progyny | $25.73 -3.7% | 5/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 | Low | View details for Cantor Fitzgerald rating of Progyny (NASDAQ:PGNY) on 5/16/2024 |
MREO Mereo BioPharma Group | $3.98 -6.4% | 5/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 5/16/2024 |
VNRX VolitionRx | $0.66 -4.3% | 5/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.50 | Low | View details for Cantor Fitzgerald rating of VolitionRx (NYSE:VNRX) on 5/16/2024 |
ABEO Abeona Therapeutics | $4.54 +0.7% | 5/16/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 5/16/2024 |
BLTE Belite Bio | $49.65 +0.1% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Belite Bio (NASDAQ:BLTE) on 5/15/2024 |
LUCD Lucid Diagnostics | $0.72 +1.4% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 5/15/2024 |
ASND Ascendis Pharma A/S | $123.19 -1.1% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 5/15/2024 |
SMTI Sanara MedTech | $29.65 +2.2% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $44.00 | Low | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 5/15/2024 |
PGEN Precigen | $1.57 -3.7% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Precigen (NASDAQ:PGEN) on 5/15/2024 |
SSTI SoundThinking | $13.45 -4.9% | 5/15/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 -> $20.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 5/15/2024 |
TSHA Taysha Gene Therapies | $2.97 -26.3% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 5/15/2024 |
IRON Disc Medicine | $43.54 -2.9% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $85.00 | Low | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 5/15/2024 |
LUNR Intuitive Machines | $3.68 -1.6% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 5/15/2024 |
CRIS Curis | $7.80 -5.1% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Curis (NASDAQ:CRIS) on 5/15/2024 |
ADI Analog Devices | $235.38 +1.3% | 5/15/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 -> $240.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 5/15/2024 |
NXPI NXP Semiconductors | $271.40 +0.1% | 5/15/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $290.00 -> $325.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 5/15/2024 |
TXN Texas Instruments | $196.25 +0.7% | 5/15/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $180.00 -> $210.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 5/15/2024 |
HL Hecla Mining | $5.15 +1.6% | 5/9/2024 | Upgraded by | Cantor Fitzgerald | Analyst M. Kozak | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Hecla Mining (NYSE:HL) on 5/9/2024 |
XGN Exagen | $1.92 -5.9% | 5/14/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of Exagen (NASDAQ:XGN) on 5/14/2024 |
DDD 3D Systems | $3.53 -0.6% | 5/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $8.25 | Low | View details for Cantor Fitzgerald rating of 3D Systems (NYSE:DDD) on 5/14/2024 |
CAPR Capricor Therapeutics | $4.84 -2.4% | 5/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Capricor Therapeutics (NASDAQ:CAPR) on 5/14/2024 |
ATOS Atossa Therapeutics | $1.12 -2.6% | 5/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Atossa Therapeutics (NASDAQ:ATOS) on 5/14/2024 |
RCEL AVITA Medical | $8.02 -1.4% | 5/14/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 5/14/2024 |
CRNX Crinetics Pharmaceuticals | $44.29 -0.9% | 5/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 5/14/2024 |
ADMA ADMA Biologics | $10.62 +1.7% | 5/10/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of ADMA Biologics (NASDAQ:ADMA) on 5/10/2024 |
ELUT Elutia | $3.27 +2.8% | 5/10/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 5/10/2024 |
RDW Redwire | $6.10 +3.4% | 5/10/2024 | Target Raised by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $5.00 -> $6.00 | Low | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 5/10/2024 |
PDSB PDS Biotechnology | $2.74 +2.6% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of PDS Biotechnology (NASDAQ:PDSB) on 5/9/2024 |
PCVX Vaxcyte | $72.25 +0.5% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 5/9/2024 |
PWSC PowerSchool | $22.35 +0.2% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of PowerSchool (NYSE:PWSC) on 5/9/2024 |
INVZ Innoviz Technologies | $0.91 -5.2% | 5/9/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Innoviz Technologies (NASDAQ:INVZ) on 5/9/2024 |
JANX Janux Therapeutics | $40.40 +0.8% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 5/9/2024 |
MIRM Mirum Pharmaceuticals | $29.25 -11.4% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $40.00 | Low | View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 5/9/2024 |
ALEC Alector | $4.26 -6.8% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Alector (NASDAQ:ALEC) on 5/9/2024 |
MKFG Markforged | $0.43 -4.4% | 5/9/2024 | Target Lowered by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $1.45 -> $1.30 | Low | View details for Cantor Fitzgerald rating of Markforged (NYSE:MKFG) on 5/9/2024 |
KVYO Klaviyo | $22.47
| 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $31.00 | Low | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 5/9/2024 |
MNKD MannKind | $4.78 +0.6% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 5/9/2024 |
LFMD LifeMD | $7.87 -6.3% | 5/9/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $15.00 | Low | View details for Cantor Fitzgerald rating of LifeMD (NASDAQ:LFMD) on 5/9/2024 |
CRSP CRISPR Therapeutics | $60.57 -2.0% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral | | Low | View details for Cantor Fitzgerald rating of CRISPR Therapeutics (NASDAQ:CRSP) on 5/9/2024 |
DCGO DocGo | $3.13
| 5/9/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of DocGo (NASDAQ:DCGO) on 5/9/2024 |
NPCE NeuroPace | $6.50
| 5/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $18.00 | Low | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 5/9/2024 |
ACAD ACADIA Pharmaceuticals | $14.87 +0.2% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/9/2024 |
CATX Perspective Therapeutics | $11.93 +15.4% | 5/9/2024 | Initiated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | N/A | View details for Cantor Fitzgerald rating of Perspective Therapeutics (NYSE:CATX) on 5/9/2024 |
The asset beating inflation by 4x (Ad) Central Bank Gold Heist In Progress
Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Precious Metals Guide, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too. Click here to get your free copy today. |
EVGO EVgo | $2.04 -2.9% | 5/9/2024 | Upgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Overweight | $5.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of EVgo (NYSE:EVGO) on 5/9/2024 |
RIVN Rivian Automotive | $11.02 +0.5% | 5/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $23.00 -> $15.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 5/8/2024 |
SHLS Shoals Technologies Group | $6.88 +3.3% | 5/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 5/8/2024 |
JNJ Johnson & Johnson | $145.65 -0.2% | 5/6/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 5/6/2024 |
GPCR Structure Therapeutics | $47.52 -2.2% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 5/3/2024 |
CYBR CyberArk Software | $255.05 +0.6% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 5/3/2024 |
REGN Regeneron Pharmaceuticals | $1,039.11 -0.6% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 5/3/2024 |
UDMY Udemy | $8.09 -1.3% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of Udemy (NASDAQ:UDMY) on 5/3/2024 |
LBPH Longboard Pharmaceuticals | $19.00 +0.9% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 5/3/2024 |
ASND Ascendis Pharma A/S | $123.19 -1.1% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 5/3/2024 |
NET Cloudflare | $79.12 +1.9% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $100.00 -> $80.00 | Low | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 5/3/2024 |
FTNT Fortinet | $59.15 -2.9% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 5/3/2024 |
CI The Cigna Group | $334.81 +0.3% | 5/3/2024 | Target Raised by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $384.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 5/3/2024 |
RARE Ultragenyx Pharmaceutical | $37.42 -6.0% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/3/2024 |
CERS Cerus | $1.69 -6.6% | 5/3/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 5/3/2024 |
SPT Sprout Social | $33.55 -0.2% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $74.00 -> $46.00 | Low | View details for Cantor Fitzgerald rating of Sprout Social (NASDAQ:SPT) on 5/3/2024 |
CGON CG Oncology | $33.89 +0.5% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $75.00 | Low | View details for Cantor Fitzgerald rating of CG Oncology (NASDAQ:CGON) on 5/2/2024 |
FRSH Freshworks | $12.10 -1.8% | 5/2/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 -> $19.00 | Low | View details for Cantor Fitzgerald rating of Freshworks (NASDAQ:FRSH) on 5/2/2024 |
CSGS CSG Systems International | $39.89 -0.5% | 5/2/2024 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $63.00 -> $62.00 | Low | View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 5/2/2024 |
QCOM QUALCOMM | $227.09 +2.2% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $190.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 5/2/2024 |
SRPT Sarepta Therapeutics | $117.52 +0.6% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $128.00 | Low | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/2/2024 |
TSLA Tesla | $184.86 -1.4% | 5/2/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $230.00 | Low | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 5/2/2024 |
CVS CVS Health | $61.02 -0.1% | 5/1/2024 | Downgraded by | Cantor Fitzgerald | Analyst S. James | Overweight -> Neutral | $87.00 -> $58.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 5/1/2024 |
AMD Advanced Micro Devices | $154.63 -2.4% | 5/1/2024 | Target Lowered by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 5/1/2024 |
FUBO fuboTV | $1.18 -0.8% | 5/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.90 | Low | View details for Cantor Fitzgerald rating of fuboTV (NYSE:FUBO) on 5/1/2024 |
LLY Eli Lilly and Company | $891.46 +0.7% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 -> $885.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/30/2024 |
NXPI NXP Semiconductors | $271.40 +0.1% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $290.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 4/30/2024 |
ATNM Actinium Pharmaceuticals | $7.88 -0.6% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 | N/A | View details for Cantor Fitzgerald rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/30/2024 |
CMPS COMPASS Pathways | $6.43 -5.4% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 4/30/2024 |
COUR Coursera | $6.43 -2.9% | 4/30/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $26.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 4/30/2024 |
ACAD ACADIA Pharmaceuticals | $14.87 +0.2% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 4/30/2024 |
TSHA Taysha Gene Therapies | $2.97 -26.3% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/30/2024 |
CMCL Caledonia Mining | $10.11 -1.3% | 4/29/2024 | Upgraded by | Cantor Fitzgerald | - | Hold -> Speculative Buy | $13.50 | N/A | View details for Cantor Fitzgerald rating of Caledonia Mining (NYSEAMERICAN:CMCL) on 4/29/2024 |
BMRN BioMarin Pharmaceutical | $84.15 -1.0% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $110.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 4/25/2024 |
HUM Humana | $349.55 -1.6% | 4/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 -> $360.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/25/2024 |
ENVX Enovix | $12.46 +2.0% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 4/25/2024 |
LRCX Lam Research | $1,089.58 +1.9% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/25/2024 |
TER Teradyne | $151.75 +4.8% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 4/25/2024 |
AMED Amedisys | $91.63 -0.2% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $101.00 | Low | View details for Cantor Fitzgerald rating of Amedisys (NASDAQ:AMED) on 4/25/2024 |
TXN Texas Instruments | $196.25 +0.7% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024 |
ITCI Intra-Cellular Therapies | $75.48 +9.6% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 4/24/2024 |
ANNX Annexon | $5.07 -5.4% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 4/24/2024 |
STX Seagate Technology | $105.99 +0.0% | 4/24/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $95.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 4/24/2024 |
MTLS Materialise | $5.00 -0.8% | 4/24/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $9.50 | Low | View details for Cantor Fitzgerald rating of Materialise (NASDAQ:MTLS) on 4/24/2024 |
ABEO Abeona Therapeutics | $4.54 +0.7% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $36.00 | N/A | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 4/23/2024 |
CDTX Cidara Therapeutics | $12.10 -3.9% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/23/2024 |
INCY Incyte | $61.44 -2.0% | 4/23/2024 | Initiated by | Cantor Fitzgerald | - | Neutral | | Low | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 4/23/2024 |
TSHA Taysha Gene Therapies | $2.97 -26.3% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/18/2024 |
ASND Ascendis Pharma A/S | $123.19 -1.1% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 4/18/2024 |
BHVN Biohaven | $32.77 -0.7% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/18/2024 |
Must-See: Elon’s New Invention is Absolutely Insane (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… |
GPCR Structure Therapeutics | $47.52 -2.2% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/18/2024 |
MRK Merck & Co., Inc. | $127.99 +0.4% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/18/2024 |
NVO Novo Nordisk A/S | $140.80 +0.3% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 4/18/2024 |
CMPS COMPASS Pathways | $6.43 -5.4% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 4/18/2024 |
COUR Coursera | $6.43 -2.9% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $26.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 4/17/2024 |
CRWD CrowdStrike | $389.51 -0.2% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 4/17/2024 |
CYBR CyberArk Software | $255.05 +0.6% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | N/A | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 4/17/2024 |
DDOG Datadog | $116.50 -0.6% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $150.00 | N/A | View details for Cantor Fitzgerald rating of Datadog (NASDAQ:DDOG) on 4/17/2024 |
FTNT Fortinet | $59.15 -2.9% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 | N/A | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 4/17/2024 |
NET Cloudflare | $79.12 +1.9% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $100.00 | N/A | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 4/17/2024 |
PANW Palo Alto Networks | $317.02 -0.8% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $350.00 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024 |
ZS Zscaler | $179.41 -2.7% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 | N/A | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 4/17/2024 |
KVYO Klaviyo | $22.47
| 4/16/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $31.00 | Low | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 4/16/2024 |
REGN Regeneron Pharmaceuticals | $1,039.11 -0.6% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 4/15/2024 |
LLY Eli Lilly and Company | $891.46 +0.7% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/15/2024 |
JNJ Johnson & Johnson | $145.65 -0.2% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 4/15/2024 |
PFE Pfizer | $27.41 +1.6% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/15/2024 |
ALXO ALX Oncology | $6.93 -6.1% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 4/12/2024 |
PSNY Polestar Automotive Holding UK | $0.69 -17.9% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Polestar Automotive Holding UK (NASDAQ:PSNY) on 4/12/2024 |
MRVL Marvell Technology | $73.14 +1.8% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $85.00 | Low | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 4/12/2024 |
HRMY Harmony Biosciences | $28.89 -1.6% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | Low | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 4/12/2024 |
PTCT PTC Therapeutics | $35.62 +0.6% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 4/12/2024 |
SOUN SoundHound AI | $4.09 -4.7% | 4/11/2024 | Upgraded by | Cantor Fitzgerald | - | Underweight -> Neutral | $4.90 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 4/11/2024 |
PRTA Prothena | $19.54 -4.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 4/10/2024 |
BHVN Biohaven | $32.77 -0.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/10/2024 |
RCM R1 RCM | $12.52 +0.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 4/10/2024 |
SGRY Surgery Partners | $25.05 -0.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 4/10/2024 |
TBRG TruBridge | $10.25 +1.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 4/10/2024 |
THC Tenet Healthcare | $137.51 +0.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 4/10/2024 |
UHS Universal Health Services | $190.56 +0.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Underweight -> Underweight | $156.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 4/10/2024 |
UNH UnitedHealth Group | $481.05 -1.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 4/10/2024 |
AWH Aspira Women's Health | $1.64 -6.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $3.30 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 4/10/2024 |
ACAD ACADIA Pharmaceuticals | $14.87 +0.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 4/10/2024 |
AXSM Axsome Therapeutics | $76.02 +0.0% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 4/10/2024 |
JAZZ Jazz Pharmaceuticals | $112.68 -1.6% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 4/10/2024 |
LBPH Longboard Pharmaceuticals | $19.00 +0.9% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 4/10/2024 |
MRNS Marinus Pharmaceuticals | $1.40 -3.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 | Low | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 4/10/2024 |
NBIX Neurocrine Biosciences | $130.86 -3.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $155.00 | Low | View details for Cantor Fitzgerald rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/10/2024 |
XENE Xenon Pharmaceuticals | $36.25 -1.0% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 4/10/2024 |
CI The Cigna Group | $334.81 +0.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $384.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 4/10/2024 |
CVS CVS Health | $61.02 -0.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 4/10/2024 |
ELV Elevance Health | $527.49 -1.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/10/2024 |
HCA HCA Healthcare | $340.65 +1.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $335.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 4/10/2024 |
HCAT Health Catalyst | $6.34 -1.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 4/10/2024 |
HUM Humana | $349.55 -1.6% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/10/2024 |
AGIO Agios Pharmaceuticals | $42.56 -0.1% | 4/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 4/9/2024 |
VINC Vincerx Pharma | $0.60 -7.7% | 4/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Vincerx Pharma (NASDAQ:VINC) on 4/9/2024 |
GPCR Structure Therapeutics | $47.52 -2.2% | 4/9/2024 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/9/2024 |
NXPI NXP Semiconductors | $271.40 +0.1% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 -> $290.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 4/8/2024 |
KLAC KLA | $863.31 +1.7% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 -> $800.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 4/8/2024 |
LRCX Lam Research | $1,089.58 +1.9% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 -> $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/8/2024 |
MU Micron Technology | $153.45 +3.8% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $135.00 -> $150.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 4/8/2024 |
QCOM QUALCOMM | $227.09 +2.2% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 -> $190.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 4/8/2024 |
TXN Texas Instruments | $196.25 +0.7% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 -> $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/8/2024 |
WDC Western Digital | $80.23 +0.5% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $70.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 4/8/2024 |
GFS GLOBALFOUNDRIES | $50.83 +0.1% | 4/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Neutral | $70.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of GLOBALFOUNDRIES (NASDAQ:GFS) on 4/8/2024 |
AMAT Applied Materials | $247.83 +2.0% | 4/8/2024 | Upgraded by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Overweight | $220.00 -> $260.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 4/8/2024 |
CABA Cabaletta Bio | $8.35 -10.8% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 4/5/2024 |
RARE Ultragenyx Pharmaceutical | $37.42 -6.0% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 4/5/2024 |
ETNB 89bio | $8.40 -5.2% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 4/5/2024 |